• The Nasdaq fell 1.21% on Wednesday to close the session at 14,442 points.
• BioNTech rallied 1.4% on Q4 results, full year results and increased COVID-19 deliveries.
• Lululemon rose 9.58% on Q4 results and Q1 forecast projecting continued growth.

The US markets reversed Tuesday’s gains to close the midweek session lower as the price of oil rebounded and investors’ fears of prolonged tensions between Russia and Ukraine continue as ceasefire talks are yet to reach a resolution.

The Dow Jones fell 0.19% to finish the trading day down 65 points to close at 35,229 points.

The tech heavy NASDAQ fell 1.21% to finish the trading day down 177 points to close at 14,442 points.

One bitcoin is worth US$47,161 going into the Asian trading day.

The Australian dollar is stronger against the major currencies and is buying 75.07 US cents.

Shares in BioNTech rose 1.4% yesterday after the biotech company released fourth-quarter and full year results. BioNTech reported fourth-quarter revenue of €5.5bn, full year revenue of €19bn, full year net income of €10.3bn and fully diluted EPS of €39.63/share. BioNTech also increased signed orders for COVID-19 vaccine doses in 2022 to 2.4bn and the company initiated the expansion of Phase 3 clinical trials to include Omicron-based candidates.

Shares in athletic apparel giant Lululemon rose almost 10% on Wednesday after the company released fourth-quarter results and guidance for Q1 and FY22. For the quarter, Lululemon revenue surged 23% to US$2.1bn, EPS was US$3.36 and full year annual revenue passed US$6bn for the first time. Lululemon also issued guidance EPS for Q1 of US$1.38 – US$1.43, and revenue of US$1.53bn – US$1.55bn, both above market expectations.

And a rare Pokemon card from 1999 has sold for a record US$420,000, as the unique card is deemed ‘the most recognisable Pokemon card ever made’.